Skip to content
Open access · CC-BY via OpenAlex

Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood

Hongdong Li, Zheng Guo, You Guo, Mengyao Li, Haidan Yan, Jun Cheng, Chenguang Wang, Guini Hong

Oncotarget · 2016 · ▲ 27 citations

Abstract

// Hongdong Li 1 , Zheng Guo 1,2 , You Guo 1,3 , Mengyao Li 1 , Haidan Yan 1 , Jun Cheng 1 , Chenguang Wang 2 and Guini Hong 1 1 Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Department of Bioinformatics, Fujian Medical University, Fuzhou, China 2 College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China 3 Department of Preventive Medicine, School of Basic Medicine Sciences, Gannan Medical University, Ganzhou, China Correspondence to: Guini Hong, email: // Chenguang Wang, email: // Keywords : aging, Alzheimer’s disease, DNA methylation, peripheral whole blood, Gerotarget Received : November 04, 2015 Accepted : February 23, 2016 Published : March 02, 2016 Abstract Alzheimer’s disease (AD) is a common aging-related neurodegenerative illness. Recently, many studies have tried to identify AD- or aging-related DNA methylation (DNAm) biomarkers from peripheral whole blood (PWB). However, the origin of PWB biomarkers is still controversial. In this study, by analyzing 2565 DNAm profiles for PWB and brain tissue, we showed that aging-related DNAm CpGs (Age-CpGs) and AD-related DNAm CpGs (AD-CpGs) observable in PWB both mainly reflected DNAm alterations intrinsic in leukocyte subtypes rather than methylation differences introduced by the increased ratio of myeloid to lymphoid cells during aging or AD progression. The PWB Age-CpGs and AD-CpGs significantly overlapped 107 sites ( P -value = 2.61×10 -12 ) and 97 had significantly concordant methylation alterations in AD and aging ( P -value < 2.2×10 -16 ), which were significantly enriched in nervous system development, neuron differentiation and neurogenesis. More than 60.8% of these 97 concordant sites were found to be significantly correlated with age in normal peripheral CD4 + T cells and CD14 + monocytes as well as in four brain regions, and 44 sites were also significantly differentially methylated in different regions of AD brain tissue. Taken together, the PWB DNAm alterations related to both aging and AD could be exploited for identification of AD biomarkers.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.18632/oncotarget.7862
Canonical
link ↗
Fetched
2026-10-04 MST

Cite this

APA
Li, H., Guo, Z., Guo, Y., Li, M., Yan, H., Cheng, J., Wang, C., &amp; Hong, G. (2016). Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood. <em>Oncotarget</em>. https://doi.org/10.18632/oncotarget.7862
Vancouver
Li H, Guo Z, Guo Y, Li M, Yan H, Cheng J, et al. Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood. Oncotarget. 2016. doi:10.18632/oncotarget.7862.
BibTeX
@article{hongdong2016Common, title = {Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood}, author = {Hongdong Li and Zheng Guo and You Guo and Mengyao Li and Haidan Yan and Jun Cheng and Chenguang Wang and Guini Hong}, journal = {Oncotarget}, year = {2016}, doi = {10.18632/oncotarget.7862}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings